nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—Psychomotor skills impaired—Ramipril—type 1 diabetes mellitus	0.0455	0.119	CcSEcCtD
Topiramate—GRIK1—peripheral nervous system—type 1 diabetes mellitus	0.0383	0.12	CbGeAlD
Topiramate—GRIA4—nerve—type 1 diabetes mellitus	0.0341	0.107	CbGeAlD
Topiramate—Pemphigoid—Ramipril—type 1 diabetes mellitus	0.0302	0.0794	CcSEcCtD
Topiramate—GRIK1—nerve—type 1 diabetes mellitus	0.0299	0.0936	CbGeAlD
Topiramate—GRIA3—nerve—type 1 diabetes mellitus	0.0278	0.087	CbGeAlD
Topiramate—CA6—saliva—type 1 diabetes mellitus	0.0258	0.0807	CbGeAlD
Topiramate—Pemphigus—Ramipril—type 1 diabetes mellitus	0.0198	0.0519	CcSEcCtD
Topiramate—GRIA1—nerve—type 1 diabetes mellitus	0.0148	0.0465	CbGeAlD
Topiramate—GRIK4—kidney—type 1 diabetes mellitus	0.0148	0.0463	CbGeAlD
Topiramate—GRIA4—retina—type 1 diabetes mellitus	0.0141	0.0442	CbGeAlD
Topiramate—GRIK3—retina—type 1 diabetes mellitus	0.013	0.0408	CbGeAlD
Topiramate—GRIK1—retina—type 1 diabetes mellitus	0.0124	0.0388	CbGeAlD
Topiramate—GRIK2—nerve—type 1 diabetes mellitus	0.0106	0.0334	CbGeAlD
Topiramate—Depressed mood—Ramipril—type 1 diabetes mellitus	0.00848	0.0223	CcSEcCtD
Topiramate—CA1—nerve—type 1 diabetes mellitus	0.00788	0.0247	CbGeAlD
Topiramate—White blood cell count decreased—Ramipril—type 1 diabetes mellitus	0.00762	0.02	CcSEcCtD
Topiramate—Balance disorder—Ramipril—type 1 diabetes mellitus	0.00693	0.0182	CcSEcCtD
Topiramate—CA9—islet of Langerhans—type 1 diabetes mellitus	0.00651	0.0204	CbGeAlD
Topiramate—CA4—nerve—type 1 diabetes mellitus	0.00616	0.0193	CbGeAlD
Topiramate—GRIA1—retina—type 1 diabetes mellitus	0.00614	0.0192	CbGeAlD
Topiramate—Parosmia—Ramipril—type 1 diabetes mellitus	0.00585	0.0153	CcSEcCtD
Topiramate—Bone marrow depression—Ramipril—type 1 diabetes mellitus	0.00562	0.0147	CcSEcCtD
Topiramate—Burning sensation—Ramipril—type 1 diabetes mellitus	0.00546	0.0143	CcSEcCtD
Topiramate—CA7—kidney—type 1 diabetes mellitus	0.00525	0.0164	CbGeAlD
Topiramate—Ageusia—Ramipril—type 1 diabetes mellitus	0.00468	0.0123	CcSEcCtD
Topiramate—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.00457	0.012	CcSEcCtD
Topiramate—GRIK2—retina—type 1 diabetes mellitus	0.00441	0.0138	CbGeAlD
Topiramate—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.00438	0.0115	CcSEcCtD
Topiramate—Glossitis—Ramipril—type 1 diabetes mellitus	0.00411	0.0108	CcSEcCtD
Topiramate—Drug interaction—Ramipril—type 1 diabetes mellitus	0.00409	0.0107	CcSEcCtD
Topiramate—Creatinine increased—Ramipril—type 1 diabetes mellitus	0.00398	0.0105	CcSEcCtD
Topiramate—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.00398	0.0105	CcSEcCtD
Topiramate—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00368	0.00967	CcSEcCtD
Topiramate—Neuropathy—Ramipril—type 1 diabetes mellitus	0.00356	0.00935	CcSEcCtD
Topiramate—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00345	0.00905	CcSEcCtD
Topiramate—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00343	0.009	CcSEcCtD
Topiramate—CA12—kidney—type 1 diabetes mellitus	0.00341	0.0107	CbGeAlD
Topiramate—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00318	0.00835	CcSEcCtD
Topiramate—Polyuria—Ramipril—type 1 diabetes mellitus	0.00313	0.00823	CcSEcCtD
Topiramate—CA5B—cardiovascular system—type 1 diabetes mellitus	0.00313	0.00979	CbGeAlD
Topiramate—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.0031	0.00815	CcSEcCtD
Topiramate—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00308	0.00808	CcSEcCtD
Topiramate—Deafness—Ramipril—type 1 diabetes mellitus	0.00308	0.00808	CcSEcCtD
Topiramate—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00306	0.00804	CcSEcCtD
Topiramate—CA5B—pancreas—type 1 diabetes mellitus	0.00304	0.00952	CbGeAlD
Topiramate—SCN5A—cardiovascular system—type 1 diabetes mellitus	0.00303	0.00949	CbGeAlD
Topiramate—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00302	0.00793	CcSEcCtD
Topiramate—CA4—islet of Langerhans—type 1 diabetes mellitus	0.00298	0.00935	CbGeAlD
Topiramate—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00297	0.00779	CcSEcCtD
Topiramate—Amnesia—Ramipril—type 1 diabetes mellitus	0.00293	0.00769	CcSEcCtD
Topiramate—Purpura—Ramipril—type 1 diabetes mellitus	0.00286	0.0075	CcSEcCtD
Topiramate—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00282	0.0074	CcSEcCtD
Topiramate—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00276	0.00725	CcSEcCtD
Topiramate—CA1—cardiovascular system—type 1 diabetes mellitus	0.00276	0.00865	CbGeAlD
Topiramate—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00273	0.00717	CcSEcCtD
Topiramate—CA1—kidney—type 1 diabetes mellitus	0.0027	0.00846	CbGeAlD
Topiramate—CA1—pancreas—type 1 diabetes mellitus	0.00268	0.00841	CbGeAlD
Topiramate—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00258	0.00677	CcSEcCtD
Topiramate—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00254	0.00667	CcSEcCtD
Topiramate—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.00251	0.0066	CcSEcCtD
Topiramate—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00251	0.0066	CcSEcCtD
Topiramate—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00249	0.00653	CcSEcCtD
Topiramate—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00248	0.00651	CcSEcCtD
Topiramate—CA2—islet of Langerhans—type 1 diabetes mellitus	0.00247	0.00775	CbGeAlD
Topiramate—Gastritis—Ramipril—type 1 diabetes mellitus	0.00244	0.00639	CcSEcCtD
Topiramate—CA4—nephron tubule—type 1 diabetes mellitus	0.0024	0.00753	CbGeAlD
Topiramate—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00238	0.00625	CcSEcCtD
Topiramate—Asthma—Ramipril—type 1 diabetes mellitus	0.00238	0.00625	CcSEcCtD
Topiramate—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00235	0.00618	CcSEcCtD
Topiramate—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00233	0.00612	CcSEcCtD
Topiramate—CA1—lymphoid tissue—type 1 diabetes mellitus	0.00232	0.00727	CbGeAlD
Topiramate—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00232	0.00608	CcSEcCtD
Topiramate—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00232	0.00608	CcSEcCtD
Topiramate—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00229	0.00601	CcSEcCtD
Topiramate—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00228	0.00599	CcSEcCtD
Topiramate—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00226	0.00593	CcSEcCtD
Topiramate—Neutropenia—Ramipril—type 1 diabetes mellitus	0.00222	0.00584	CcSEcCtD
Topiramate—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00221	0.0058	CcSEcCtD
Topiramate—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00219	0.00575	CcSEcCtD
Topiramate—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00217	0.0057	CcSEcCtD
Topiramate—Weight increased—Ramipril—type 1 diabetes mellitus	0.00216	0.00568	CcSEcCtD
Topiramate—CA4—cardiovascular system—type 1 diabetes mellitus	0.00216	0.00676	CbGeAlD
Topiramate—CA2—retina—type 1 diabetes mellitus	0.00212	0.00663	CbGeAlD
Topiramate—CA4—kidney—type 1 diabetes mellitus	0.00211	0.00661	CbGeAlD
Topiramate—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.0021	0.00552	CcSEcCtD
Topiramate—Renal failure—Ramipril—type 1 diabetes mellitus	0.00208	0.00547	CcSEcCtD
Topiramate—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00208	0.00546	CcSEcCtD
Topiramate—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00207	0.00543	CcSEcCtD
Topiramate—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00206	0.00541	CcSEcCtD
Topiramate—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00206	0.00541	CcSEcCtD
Topiramate—Epistaxis—Ramipril—type 1 diabetes mellitus	0.002	0.00525	CcSEcCtD
Topiramate—CA2—nephron tubule—type 1 diabetes mellitus	0.00199	0.00624	CbGeAlD
Topiramate—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00199	0.00522	CcSEcCtD
Topiramate—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00198	0.0052	CcSEcCtD
Topiramate—Hepatitis—Ramipril—type 1 diabetes mellitus	0.0019	0.005	CcSEcCtD
Topiramate—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00188	0.00492	CcSEcCtD
Topiramate—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00187	0.00491	CcSEcCtD
Topiramate—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00183	0.00482	CcSEcCtD
Topiramate—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.0018	0.00473	CcSEcCtD
Topiramate—CA2—cardiovascular system—type 1 diabetes mellitus	0.00179	0.00561	CbGeAlD
Topiramate—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00178	0.00466	CcSEcCtD
Topiramate—Flushing—Ramipril—type 1 diabetes mellitus	0.00177	0.00464	CcSEcCtD
Topiramate—CA2—kidney—type 1 diabetes mellitus	0.00175	0.00548	CbGeAlD
Topiramate—CA2—pancreas—type 1 diabetes mellitus	0.00174	0.00545	CbGeAlD
Topiramate—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00172	0.00452	CcSEcCtD
Topiramate—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00172	0.00451	CcSEcCtD
Topiramate—Alopecia—Ramipril—type 1 diabetes mellitus	0.00168	0.00442	CcSEcCtD
Topiramate—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00167	0.00438	CcSEcCtD
Topiramate—Erythema—Ramipril—type 1 diabetes mellitus	0.00166	0.00435	CcSEcCtD
Topiramate—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00166	0.00435	CcSEcCtD
Topiramate—Tension—Ramipril—type 1 diabetes mellitus	0.00163	0.00427	CcSEcCtD
Topiramate—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00162	0.00426	CcSEcCtD
Topiramate—Nervousness—Ramipril—type 1 diabetes mellitus	0.00161	0.00423	CcSEcCtD
Topiramate—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00159	0.00418	CcSEcCtD
Topiramate—Tremor—Ramipril—type 1 diabetes mellitus	0.00155	0.00408	CcSEcCtD
Topiramate—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00154	0.00404	CcSEcCtD
Topiramate—Agitation—Ramipril—type 1 diabetes mellitus	0.00152	0.004	CcSEcCtD
Topiramate—CA2—lymphoid tissue—type 1 diabetes mellitus	0.0015	0.00471	CbGeAlD
Topiramate—Malaise—Ramipril—type 1 diabetes mellitus	0.00149	0.00392	CcSEcCtD
Topiramate—Vertigo—Ramipril—type 1 diabetes mellitus	0.00149	0.00391	CcSEcCtD
Topiramate—Syncope—Ramipril—type 1 diabetes mellitus	0.00149	0.0039	CcSEcCtD
Topiramate—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00148	0.0039	CcSEcCtD
Topiramate—Palpitations—Ramipril—type 1 diabetes mellitus	0.00146	0.00385	CcSEcCtD
Topiramate—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00146	0.00382	CcSEcCtD
Topiramate—Cough—Ramipril—type 1 diabetes mellitus	0.00145	0.0038	CcSEcCtD
Topiramate—Convulsion—Ramipril—type 1 diabetes mellitus	0.00144	0.00377	CcSEcCtD
Topiramate—Chest pain—Ramipril—type 1 diabetes mellitus	0.00141	0.0037	CcSEcCtD
Topiramate—Myalgia—Ramipril—type 1 diabetes mellitus	0.00141	0.0037	CcSEcCtD
Topiramate—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00141	0.0037	CcSEcCtD
Topiramate—Anxiety—Ramipril—type 1 diabetes mellitus	0.00141	0.00369	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.0014	0.00368	CcSEcCtD
Topiramate—Discomfort—Ramipril—type 1 diabetes mellitus	0.00139	0.00366	CcSEcCtD
Topiramate—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00138	0.00362	CcSEcCtD
Topiramate—Confusional state—Ramipril—type 1 diabetes mellitus	0.00136	0.00358	CcSEcCtD
Topiramate—Oedema—Ramipril—type 1 diabetes mellitus	0.00135	0.00355	CcSEcCtD
Topiramate—Shock—Ramipril—type 1 diabetes mellitus	0.00133	0.00349	CcSEcCtD
Topiramate—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00133	0.00348	CcSEcCtD
Topiramate—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00132	0.00348	CcSEcCtD
Topiramate—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00132	0.00347	CcSEcCtD
Topiramate—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00131	0.00345	CcSEcCtD
Topiramate—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00131	0.00343	CcSEcCtD
Topiramate—Anorexia—Ramipril—type 1 diabetes mellitus	0.00129	0.00339	CcSEcCtD
Topiramate—Hypotension—Ramipril—type 1 diabetes mellitus	0.00126	0.00332	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00123	0.00324	CcSEcCtD
Topiramate—Insomnia—Ramipril—type 1 diabetes mellitus	0.00122	0.00321	CcSEcCtD
Topiramate—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00121	0.00319	CcSEcCtD
Topiramate—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00121	0.00317	CcSEcCtD
Topiramate—Somnolence—Ramipril—type 1 diabetes mellitus	0.0012	0.00316	CcSEcCtD
Topiramate—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00119	0.00313	CcSEcCtD
Topiramate—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00118	0.00309	CcSEcCtD
Topiramate—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00117	0.00307	CcSEcCtD
Topiramate—Fatigue—Ramipril—type 1 diabetes mellitus	0.00117	0.00306	CcSEcCtD
Topiramate—Constipation—Ramipril—type 1 diabetes mellitus	0.00116	0.00304	CcSEcCtD
Topiramate—CYP3A4—kidney—type 1 diabetes mellitus	0.00113	0.00354	CbGeAlD
Topiramate—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00111	0.00293	CcSEcCtD
Topiramate—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00111	0.0029	CcSEcCtD
Topiramate—Urticaria—Ramipril—type 1 diabetes mellitus	0.00107	0.00282	CcSEcCtD
Topiramate—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00107	0.00281	CcSEcCtD
Topiramate—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00107	0.00281	CcSEcCtD
Topiramate—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000997	0.00262	CcSEcCtD
Topiramate—Asthenia—Ramipril—type 1 diabetes mellitus	0.00097	0.00255	CcSEcCtD
Topiramate—Pruritus—Ramipril—type 1 diabetes mellitus	0.000957	0.00251	CcSEcCtD
Topiramate—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000925	0.00243	CcSEcCtD
Topiramate—Dizziness—Ramipril—type 1 diabetes mellitus	0.000894	0.00235	CcSEcCtD
Topiramate—Vomiting—Ramipril—type 1 diabetes mellitus	0.00086	0.00226	CcSEcCtD
Topiramate—Rash—Ramipril—type 1 diabetes mellitus	0.000853	0.00224	CcSEcCtD
Topiramate—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000852	0.00224	CcSEcCtD
Topiramate—Headache—Ramipril—type 1 diabetes mellitus	0.000847	0.00222	CcSEcCtD
Topiramate—Nausea—Ramipril—type 1 diabetes mellitus	0.000803	0.00211	CcSEcCtD
Topiramate—GRIA2—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.000547	0.00182	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—GAD1—type 1 diabetes mellitus	0.000542	0.00181	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—ABCC8—type 1 diabetes mellitus	0.000537	0.00179	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.000537	0.00179	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.000531	0.00177	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—CD4—type 1 diabetes mellitus	0.000519	0.00173	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CHRM2—type 1 diabetes mellitus	0.000508	0.00169	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—PAX4—type 1 diabetes mellitus	0.000506	0.00169	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CACNA1G—type 1 diabetes mellitus	0.000506	0.00169	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.000503	0.00168	CbGpPWpGaD
Topiramate—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—type 1 diabetes mellitus	0.000499	0.00166	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—STAT3—type 1 diabetes mellitus	0.000497	0.00166	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—ABCC8—type 1 diabetes mellitus	0.000491	0.00164	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.000491	0.00164	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—GAD2—type 1 diabetes mellitus	0.00049	0.00163	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.000486	0.00162	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—GAD2—type 1 diabetes mellitus	0.000469	0.00156	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.000439	0.00146	CbGpPWpGaD
Topiramate—CA6—Metabolism—HBA2—type 1 diabetes mellitus	0.000437	0.00146	CbGpPWpGaD
Topiramate—CA5A—Metabolism—HBA2—type 1 diabetes mellitus	0.000437	0.00146	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—PDX1—type 1 diabetes mellitus	0.00043	0.00143	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—HNF1A—type 1 diabetes mellitus	0.00043	0.00143	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—GAD2—type 1 diabetes mellitus	0.000429	0.00143	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—ABCC8—type 1 diabetes mellitus	0.000429	0.00143	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.000429	0.00143	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.000425	0.00142	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.000425	0.00142	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.000411	0.00137	CbGpPWpGaD
Topiramate—CA6—Metabolism—G6PC2—type 1 diabetes mellitus	0.000411	0.00137	CbGpPWpGaD
Topiramate—CA5A—Metabolism—G6PC2—type 1 diabetes mellitus	0.000411	0.00137	CbGpPWpGaD
Topiramate—CA7—Metabolism—HBA2—type 1 diabetes mellitus	0.000408	0.00136	CbGpPWpGaD
Topiramate—CA5B—Metabolism—HBA2—type 1 diabetes mellitus	0.000408	0.00136	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—GAD1—type 1 diabetes mellitus	0.000407	0.00136	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.000405	0.00135	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.000388	0.00129	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—PRKCQ—type 1 diabetes mellitus	0.000387	0.00129	CbGpPWpGaD
Topiramate—CA7—Metabolism—G6PC2—type 1 diabetes mellitus	0.000383	0.00128	CbGpPWpGaD
Topiramate—CA5B—Metabolism—G6PC2—type 1 diabetes mellitus	0.000383	0.00128	CbGpPWpGaD
Topiramate—CA12—Metabolism—HBA2—type 1 diabetes mellitus	0.000378	0.00126	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.000376	0.00125	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—GAD2—type 1 diabetes mellitus	0.000375	0.00125	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	0.000375	0.00125	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—GAD1—type 1 diabetes mellitus	0.000372	0.00124	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—IAPP—type 1 diabetes mellitus	0.000366	0.00122	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ABCC8—type 1 diabetes mellitus	0.000356	0.00119	CbGpPWpGaD
Topiramate—CA6—Metabolism—ABCC8—type 1 diabetes mellitus	0.000356	0.00119	CbGpPWpGaD
Topiramate—CA12—Metabolism—G6PC2—type 1 diabetes mellitus	0.000355	0.00118	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—CASP3—type 1 diabetes mellitus	0.000355	0.00118	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—CAT—type 1 diabetes mellitus	0.000341	0.00114	CbGpPWpGaD
Topiramate—SCN1A—L1CAM interactions—EGFR—type 1 diabetes mellitus	0.00034	0.00113	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.000339	0.00113	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000333	0.00111	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ABCC8—type 1 diabetes mellitus	0.000332	0.00111	CbGpPWpGaD
Topiramate—CA7—Metabolism—ABCC8—type 1 diabetes mellitus	0.000332	0.00111	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.000329	0.0011	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—GAD1—type 1 diabetes mellitus	0.000325	0.00108	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—SOD2—type 1 diabetes mellitus	0.000323	0.00108	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—E2F1—type 1 diabetes mellitus	0.000311	0.00104	CbGpPWpGaD
Topiramate—CA12—Metabolism—ABCC8—type 1 diabetes mellitus	0.000308	0.00103	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000305	0.00102	CbGpPWpGaD
Topiramate—CA4—Metabolism—HBA2—type 1 diabetes mellitus	0.000301	0.001	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—STAT3—type 1 diabetes mellitus	0.000298	0.000993	CbGpPWpGaD
Topiramate—CA2—Metabolism—HBA2—type 1 diabetes mellitus	0.000289	0.000963	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000289	0.000963	CbGpPWpGaD
Topiramate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.000287	0.000956	CbGpPWpGaD
Topiramate—CA4—Metabolism—G6PC2—type 1 diabetes mellitus	0.000283	0.000944	CbGpPWpGaD
Topiramate—CA6—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000282	0.000938	CbGpPWpGaD
Topiramate—CA5A—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000282	0.000938	CbGpPWpGaD
Topiramate—CA1—Metabolism—HBA2—type 1 diabetes mellitus	0.000277	0.000923	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—PRKCQ—type 1 diabetes mellitus	0.000276	0.00092	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—PRKCQ—type 1 diabetes mellitus	0.000272	0.000906	CbGpPWpGaD
Topiramate—CA2—Metabolism—G6PC2—type 1 diabetes mellitus	0.000272	0.000905	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.000267	0.00089	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000266	0.000888	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000264	0.00088	CbGpPWpGaD
Topiramate—CA5B—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000263	0.000876	CbGpPWpGaD
Topiramate—CA7—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000263	0.000876	CbGpPWpGaD
Topiramate—CA1—Metabolism—G6PC2—type 1 diabetes mellitus	0.00026	0.000868	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—IAPP—type 1 diabetes mellitus	0.000257	0.000858	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—CDK4—type 1 diabetes mellitus	0.000254	0.000846	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—CASP3—type 1 diabetes mellitus	0.000248	0.000827	CbGpPWpGaD
Topiramate—CA4—Metabolism—ABCC8—type 1 diabetes mellitus	0.000246	0.000819	CbGpPWpGaD
Topiramate—CA9—Metabolism—HBA2—type 1 diabetes mellitus	0.000243	0.000812	CbGpPWpGaD
Topiramate—CA12—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000243	0.000812	CbGpPWpGaD
Topiramate—SCN5A—L1CAM interactions—EGFR—type 1 diabetes mellitus	0.000239	0.000796	CbGpPWpGaD
Topiramate—CA6—Metabolism—ITPR3—type 1 diabetes mellitus	0.000238	0.000792	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ITPR3—type 1 diabetes mellitus	0.000238	0.000792	CbGpPWpGaD
Topiramate—CA2—Metabolism—ABCC8—type 1 diabetes mellitus	0.000235	0.000785	CbGpPWpGaD
Topiramate—CYP3A4—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.000232	0.000773	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000231	0.00077	CbGpPWpGaD
Topiramate—CA9—Metabolism—G6PC2—type 1 diabetes mellitus	0.000229	0.000763	CbGpPWpGaD
Topiramate—CA1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000226	0.000753	CbGpPWpGaD
Topiramate—CA5A—Metabolism—HBA1—type 1 diabetes mellitus	0.000224	0.000745	CbGpPWpGaD
Topiramate—CA6—Metabolism—HBA1—type 1 diabetes mellitus	0.000224	0.000745	CbGpPWpGaD
Topiramate—CA6—Metabolism—APOC3—type 1 diabetes mellitus	0.000222	0.000741	CbGpPWpGaD
Topiramate—CA5A—Metabolism—APOC3—type 1 diabetes mellitus	0.000222	0.000741	CbGpPWpGaD
Topiramate—CA7—Metabolism—ITPR3—type 1 diabetes mellitus	0.000222	0.000739	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ITPR3—type 1 diabetes mellitus	0.000222	0.000739	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000221	0.000737	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GSTT1—type 1 diabetes mellitus	0.000218	0.000728	CbGpPWpGaD
Topiramate—CA6—Metabolism—GSTT1—type 1 diabetes mellitus	0.000218	0.000728	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.000212	0.000708	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.000212	0.000707	CbGpPWpGaD
Topiramate—CA7—Metabolism—HBA1—type 1 diabetes mellitus	0.000209	0.000696	CbGpPWpGaD
Topiramate—CA5B—Metabolism—HBA1—type 1 diabetes mellitus	0.000209	0.000696	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—STAT3—type 1 diabetes mellitus	0.000208	0.000695	CbGpPWpGaD
Topiramate—CA7—Metabolism—APOC3—type 1 diabetes mellitus	0.000207	0.000692	CbGpPWpGaD
Topiramate—CA5B—Metabolism—APOC3—type 1 diabetes mellitus	0.000207	0.000692	CbGpPWpGaD
Topiramate—CA12—Metabolism—ITPR3—type 1 diabetes mellitus	0.000206	0.000685	CbGpPWpGaD
Topiramate—CA7—Metabolism—GSTT1—type 1 diabetes mellitus	0.000204	0.000679	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GSTT1—type 1 diabetes mellitus	0.000204	0.000679	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000203	0.000678	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000202	0.000674	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000202	0.000673	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—TYK2—type 1 diabetes mellitus	0.000202	0.000672	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000199	0.000664	CbGpPWpGaD
Topiramate—CA9—Metabolism—ABCC8—type 1 diabetes mellitus	0.000198	0.000662	CbGpPWpGaD
Topiramate—CA4—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000194	0.000647	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—PRKCQ—type 1 diabetes mellitus	0.000194	0.000647	CbGpPWpGaD
Topiramate—CA12—Metabolism—HBA1—type 1 diabetes mellitus	0.000193	0.000645	CbGpPWpGaD
Topiramate—CA12—Metabolism—APOC3—type 1 diabetes mellitus	0.000192	0.000641	CbGpPWpGaD
Topiramate—CA12—Metabolism—GSTT1—type 1 diabetes mellitus	0.000189	0.000629	CbGpPWpGaD
Topiramate—CA2—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000186	0.000621	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000186	0.00062	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000185	0.000615	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—CDK4—type 1 diabetes mellitus	0.000181	0.000603	CbGpPWpGaD
Topiramate—CA1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000178	0.000595	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000177	0.000589	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GCG—type 1 diabetes mellitus	0.000174	0.00058	CbGpPWpGaD
Topiramate—CA6—Metabolism—GCG—type 1 diabetes mellitus	0.000174	0.00058	CbGpPWpGaD
Topiramate—CA4—Metabolism—ITPR3—type 1 diabetes mellitus	0.000164	0.000546	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000163	0.000542	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GCG—type 1 diabetes mellitus	0.000162	0.000541	CbGpPWpGaD
Topiramate—CA7—Metabolism—GCG—type 1 diabetes mellitus	0.000162	0.000541	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000161	0.000538	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—INS—type 1 diabetes mellitus	0.000161	0.000537	CbGpPWpGaD
Topiramate—CA2—Metabolism—ITPR3—type 1 diabetes mellitus	0.000157	0.000524	CbGpPWpGaD
Topiramate—CA9—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000157	0.000523	CbGpPWpGaD
Topiramate—CA4—Metabolism—HBA1—type 1 diabetes mellitus	0.000154	0.000514	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000154	0.000514	CbGpPWpGaD
Topiramate—CA4—Metabolism—APOC3—type 1 diabetes mellitus	0.000153	0.000511	CbGpPWpGaD
Topiramate—CA1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000151	0.000502	CbGpPWpGaD
Topiramate—CA4—Metabolism—GSTT1—type 1 diabetes mellitus	0.000151	0.000502	CbGpPWpGaD
Topiramate—CA12—Metabolism—GCG—type 1 diabetes mellitus	0.00015	0.000501	CbGpPWpGaD
Topiramate—CA2—Metabolism—HBA1—type 1 diabetes mellitus	0.000148	0.000493	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CAT—type 1 diabetes mellitus	0.000147	0.000491	CbGpPWpGaD
Topiramate—CA6—Metabolism—CAT—type 1 diabetes mellitus	0.000147	0.000491	CbGpPWpGaD
Topiramate—CA2—Metabolism—APOC3—type 1 diabetes mellitus	0.000147	0.00049	CbGpPWpGaD
Topiramate—CA2—Metabolism—GSTT1—type 1 diabetes mellitus	0.000144	0.000481	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TYK2—type 1 diabetes mellitus	0.000144	0.00048	CbGpPWpGaD
Topiramate—CA1—Metabolism—HBA1—type 1 diabetes mellitus	0.000142	0.000473	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—TYK2—type 1 diabetes mellitus	0.000142	0.000473	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—STAT3—type 1 diabetes mellitus	0.000141	0.000471	CbGpPWpGaD
Topiramate—CA1—Metabolism—APOC3—type 1 diabetes mellitus	0.000141	0.00047	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.00014	0.000467	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.00014	0.000466	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000138	0.000461	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CAT—type 1 diabetes mellitus	0.000137	0.000458	CbGpPWpGaD
Topiramate—CA7—Metabolism—CAT—type 1 diabetes mellitus	0.000137	0.000458	CbGpPWpGaD
Topiramate—CA9—Metabolism—ITPR3—type 1 diabetes mellitus	0.000132	0.000441	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—EGFR—type 1 diabetes mellitus	0.000128	0.000428	CbGpPWpGaD
Topiramate—CA12—Metabolism—CAT—type 1 diabetes mellitus	0.000127	0.000424	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CDK4—type 1 diabetes mellitus	0.000127	0.000424	CbGpPWpGaD
Topiramate—CA9—Metabolism—HBA1—type 1 diabetes mellitus	0.000125	0.000415	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.000124	0.000415	CbGpPWpGaD
Topiramate—CA9—Metabolism—APOC3—type 1 diabetes mellitus	0.000124	0.000413	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTT1—type 1 diabetes mellitus	0.000122	0.000406	CbGpPWpGaD
Topiramate—CA4—Metabolism—GCG—type 1 diabetes mellitus	0.00012	0.0004	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.00012	0.000399	CbGpPWpGaD
Topiramate—CA2—Metabolism—GCG—type 1 diabetes mellitus	0.000115	0.000383	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—INS—type 1 diabetes mellitus	0.000113	0.000377	CbGpPWpGaD
Topiramate—CA1—Metabolism—GCG—type 1 diabetes mellitus	0.00011	0.000368	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000102	0.000339	CbGpPWpGaD
Topiramate—CA4—Metabolism—CAT—type 1 diabetes mellitus	0.000102	0.000338	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TYK2—type 1 diabetes mellitus	0.000101	0.000337	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—STAT3—type 1 diabetes mellitus	0.000101	0.000336	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—IL6—type 1 diabetes mellitus	9.88e-05	0.000329	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—IL6—type 1 diabetes mellitus	9.86e-05	0.000329	CbGpPWpGaD
Topiramate—CA5A—Metabolism—INS—type 1 diabetes mellitus	9.77e-05	0.000326	CbGpPWpGaD
Topiramate—CA6—Metabolism—INS—type 1 diabetes mellitus	9.77e-05	0.000326	CbGpPWpGaD
Topiramate—CA2—Metabolism—CAT—type 1 diabetes mellitus	9.74e-05	0.000325	CbGpPWpGaD
Topiramate—CA9—Metabolism—GCG—type 1 diabetes mellitus	9.69e-05	0.000323	CbGpPWpGaD
Topiramate—CA1—Metabolism—CAT—type 1 diabetes mellitus	9.33e-05	0.000311	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—EGFR—type 1 diabetes mellitus	9.16e-05	0.000305	CbGpPWpGaD
Topiramate—CA7—Metabolism—INS—type 1 diabetes mellitus	9.12e-05	0.000304	CbGpPWpGaD
Topiramate—CA5B—Metabolism—INS—type 1 diabetes mellitus	9.12e-05	0.000304	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—EGFR—type 1 diabetes mellitus	9.02e-05	0.000301	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ALB—type 1 diabetes mellitus	8.96e-05	0.000299	CbGpPWpGaD
Topiramate—CA6—Metabolism—ALB—type 1 diabetes mellitus	8.96e-05	0.000299	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TNF—type 1 diabetes mellitus	8.72e-05	0.000291	CbGpPWpGaD
Topiramate—CA5A—Metabolism—NOS3—type 1 diabetes mellitus	8.57e-05	0.000286	CbGpPWpGaD
Topiramate—CA6—Metabolism—NOS3—type 1 diabetes mellitus	8.57e-05	0.000286	CbGpPWpGaD
Topiramate—CA12—Metabolism—INS—type 1 diabetes mellitus	8.45e-05	0.000282	CbGpPWpGaD
Topiramate—CA7—Metabolism—ALB—type 1 diabetes mellitus	8.36e-05	0.000279	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ALB—type 1 diabetes mellitus	8.36e-05	0.000279	CbGpPWpGaD
Topiramate—CA9—Metabolism—CAT—type 1 diabetes mellitus	8.21e-05	0.000274	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	8.2e-05	0.000273	CbGpPWpGaD
Topiramate—CA5B—Metabolism—NOS3—type 1 diabetes mellitus	8e-05	0.000267	CbGpPWpGaD
Topiramate—CA7—Metabolism—NOS3—type 1 diabetes mellitus	8e-05	0.000267	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	7.79e-05	0.00026	CbGpPWpGaD
Topiramate—CA12—Metabolism—ALB—type 1 diabetes mellitus	7.75e-05	0.000258	CbGpPWpGaD
Topiramate—CA12—Metabolism—NOS3—type 1 diabetes mellitus	7.41e-05	0.000247	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	7.26e-05	0.000242	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—STAT3—type 1 diabetes mellitus	7.08e-05	0.000236	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—IL6—type 1 diabetes mellitus	7.04e-05	0.000235	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—IL6—type 1 diabetes mellitus	6.93e-05	0.000231	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HBA2—type 1 diabetes mellitus	6.82e-05	0.000227	CbGpPWpGaD
Topiramate—CA4—Metabolism—INS—type 1 diabetes mellitus	6.74e-05	0.000225	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	6.64e-05	0.000221	CbGpPWpGaD
Topiramate—CA2—Metabolism—INS—type 1 diabetes mellitus	6.46e-05	0.000215	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EGFR—type 1 diabetes mellitus	6.44e-05	0.000215	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—G6PC2—type 1 diabetes mellitus	6.41e-05	0.000214	CbGpPWpGaD
Topiramate—CA1—Metabolism—INS—type 1 diabetes mellitus	6.2e-05	0.000207	CbGpPWpGaD
Topiramate—CA4—Metabolism—ALB—type 1 diabetes mellitus	6.18e-05	0.000206	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—type 1 diabetes mellitus	6.13e-05	0.000204	CbGpPWpGaD
Topiramate—CA2—Metabolism—ALB—type 1 diabetes mellitus	5.92e-05	0.000197	CbGpPWpGaD
Topiramate—CA4—Metabolism—NOS3—type 1 diabetes mellitus	5.91e-05	0.000197	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	5.81e-05	0.000194	CbGpPWpGaD
Topiramate—CA1—Metabolism—ALB—type 1 diabetes mellitus	5.68e-05	0.000189	CbGpPWpGaD
Topiramate—CA2—Metabolism—NOS3—type 1 diabetes mellitus	5.67e-05	0.000189	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCC8—type 1 diabetes mellitus	5.56e-05	0.000185	CbGpPWpGaD
Topiramate—CA9—Metabolism—INS—type 1 diabetes mellitus	5.45e-05	0.000182	CbGpPWpGaD
Topiramate—CA1—Metabolism—NOS3—type 1 diabetes mellitus	5.43e-05	0.000181	CbGpPWpGaD
Topiramate—CA9—Metabolism—ALB—type 1 diabetes mellitus	4.99e-05	0.000166	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—IL6—type 1 diabetes mellitus	4.95e-05	0.000165	CbGpPWpGaD
Topiramate—CA9—Metabolism—NOS3—type 1 diabetes mellitus	4.78e-05	0.000159	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	4.39e-05	0.000146	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	4.1e-05	0.000137	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	3.85e-05	0.000128	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	3.71e-05	0.000124	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	3.49e-05	0.000116	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	3.47e-05	0.000116	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	3.41e-05	0.000114	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	3.34e-05	0.000111	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	3.14e-05	0.000105	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	2.71e-05	9.05e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	2.64e-05	8.8e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	2.3e-05	7.66e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	2.23e-05	7.43e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	2.1e-05	6.99e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	2.09e-05	6.95e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	2.05e-05	6.83e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	1.63e-05	5.44e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	1.52e-05	5.08e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	1.4e-05	4.66e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	1.38e-05	4.6e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	1.34e-05	4.46e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	9.17e-06	3.06e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	8.41e-06	2.8e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	8.04e-06	2.68e-05	CbGpPWpGaD
